Aubagio Slows Grey Matter, Whole Brain Atrophy in CIS, Study Finds

Share This Story, Choose Your Platform!

Studied for the first time, Aubagio (teriflunomide) slowed the loss of cortical grey matter and whole-brain volume in people with clinically isolated syndrome (CIS) during two years of therapy, a study found. The treatment was especially effective in those without brain lesions before treatment. Read more…